Ayr Wellness (OTCMKTS:AYRWF – Get Rating) is one of 52 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare Ayr Wellness to related businesses based on the strength of its valuation, analyst recommendations, risk, profitability, dividends, earnings and institutional ownership.
Earnings & Valuation
This table compares Ayr Wellness and its rivals top-line revenue, earnings per share and valuation.
Gross Revenue Net Income Price/Earnings Ratio Ayr Wellness $357.61 million -$16.95 million -27.89 Ayr Wellness Competitors $265.50 million -$63.33 million -9.20
Ayr Wellness has higher revenue and earnings than its rivals. Ayr Wellness is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Insider & Institutional Ownership 0.3% of Ayr Wellness shares are held by institutional investors. Comparatively, 16.1% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 25.2% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe